Re: Another question re: IPO's

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

PVLee

Rank: Mail Room [?]

Points: 183 [?]

Votes: 1 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Another question re: IPO's

in response to

Another question re: IPO's

PVLee

posted on Dec 10, 2015 09:55AM

I probably should have said preferred shares (for the royalties). Enough from me. P VLee

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply